BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16823856)

  • 21. [Inclusion body myositis. Report of 4 cases].
    Basquiera AL; Caeiro F; Palacio S; Theaux R; Casale A; Lucero C; Alvarellos A
    Medicina (B Aires); 2002; 62(1):37-40. PubMed ID: 11965848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of inclusion body myositis (IBM) associated with lipid-storage vacuoles].
    Hida C; Endo K; Hirayama K; Awano H; Yamamoto T
    Rinsho Shinkeigaku; 1995 Apr; 35(4):396-402. PubMed ID: 7614766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Gne knockout mouse expressing human V572L mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.
    Malicdan MC; Noguchi S; Nonaka I; Hayashi YK; Nishino I
    Hum Mol Genet; 2007 Jan; 16(2):115-28. PubMed ID: 17164266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ubiquitin immunostaining and inclusion body myositis: study of 30 patients with inclusion body myositis.
    Prayson RA; Cohen ML
    Hum Pathol; 1997 Aug; 28(8):887-92. PubMed ID: 9269823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase in nuclei and rimmed vacuoles of muscle fibers in DMRV (distal myopathy with rimmed vacuoles).
    Ishihara S; Tomimitsu H; Fujigasaki H; Saito F; Mizusawa H
    J Med Dent Sci; 2008 Mar; 55(1):181-7. PubMed ID: 19845164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle weakness correlates with muscle atrophy and precedes the development of inclusion body or rimmed vacuoles in the mouse model of DMRV/hIBM.
    Malicdan MC; Noguchi S; Hayashi YK; Nishino I
    Physiol Genomics; 2008 Sep; 35(1):106-15. PubMed ID: 18628337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bcl-2, Bcl-x, and Bax expression by immunohistochemistry in inclusion body myositis: a study of 27 cases.
    Prayson RA; Yu AC
    Arch Pathol Lab Med; 2001 Oct; 125(10):1326-30. PubMed ID: 11570908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inclusion body myositis and paraproteinemia: incidence and immunopathologic correlations.
    Dalakas MC; Illa I; Gallardo E; Juarez C
    Ann Neurol; 1997 Jan; 41(1):100-4. PubMed ID: 9005871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myositis with endomysial cell invasion indicates inclusion body myositis even if other criteria are not fulfilled.
    van de Vlekkert J; Hoogendijk JE; de Visser M
    Neuromuscul Disord; 2015 Jun; 25(6):451-6. PubMed ID: 25817837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rimmed vacuoles with beta-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): similarities with inclusion body myositis.
    Semino-Mora C; Dalakas MC
    Hum Pathol; 1998 Oct; 29(10):1128-33. PubMed ID: 9781653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.
    Larman HB; Salajegheh M; Nazareno R; Lam T; Sauld J; Steen H; Kong SW; Pinkus JL; Amato AA; Elledge SJ; Greenberg SA
    Ann Neurol; 2013 Mar; 73(3):408-18. PubMed ID: 23596012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis.
    Britson KA; Ling JP; Braunstein KE; Montagne JM; Kastenschmidt JM; Wilson A; Ikenaga C; Tsao W; Pinal-Fernandez I; Russell KA; Reed N; Mozaffar T; Wagner KR; Ostrow LW; Corse AM; Mammen AL; Villalta SA; Larman HB; Wong PC; Lloyd TE
    Sci Transl Med; 2022 Jan; 14(628):eabi9196. PubMed ID: 35044790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inclusion body myositis (IBM). Morphological study.
    FidziaƄska A; Drac H; Glinka Z
    Neuropatol Pol; 1992; 30(3-4):199-207. PubMed ID: 1340913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.
    Askanas V; Engel WK
    Neurology; 2006 Jan; 66(2 Suppl 1):S39-48. PubMed ID: 16432144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical forms of inclusion body myositis: 12 cases].
    Serratrice G; Pellissier JF; Pouget J; Figarella-Branger D
    Rev Neurol (Paris); 1989; 145(11):781-8. PubMed ID: 2556772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conspicuous accumulation of a single-stranded DNA binding protein in skeletal muscle fibers in inclusion body myositis.
    Nalbantoglu J; Karpati G; Carpenter S
    Am J Pathol; 1994 May; 144(5):874-82. PubMed ID: 8178939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The origins of rimmed vacuoles and granulovacuolar degeneration bodies are associated with the Wnt signaling pathway.
    Murata-Shinozaki Y; Takahashi T; Matsubara T; Maruyama H; Izumi Y; Matsumoto M
    Neurosci Lett; 2017 Jan; 638():55-59. PubMed ID: 27939356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myopathy in a rhesus monkey with biopsy findings similar to human sporadic inclusion body myositis.
    Skuk D; Goulet M; Paradis M; Tremblay JP
    Neuromuscul Disord; 2013 Feb; 23(2):155-9. PubMed ID: 23200905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial abnormalities in inclusion-body myositis.
    Oldfors A; Moslemi AR; Jonasson L; Ohlsson M; Kollberg G; Lindberg C
    Neurology; 2006 Jan; 66(2 Suppl 1):S49-55. PubMed ID: 16432145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late-onset distal myopathy with rimmed vacuoles without mutation in the GNE or dysferlin genes.
    Suzuki N; Aoki M; Mizuno H; Onodera Y; Takahashi T; Nagata T; Tateyama M; Itoyama Y
    Muscle Nerve; 2005 Dec; 32(6):812-4. PubMed ID: 16116644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.